<table border="1"><tr><th>Type</th><td>Public</td></tr><tr><th>Traded as</th><td>Nasdaq: REGN | Nasdaq-100 component | S&amp;P 500 component</td></tr><tr><th>Industry</th><td>Pharmaceuticals; Biotech</td></tr><tr><th>Founded</th><td>1988 | ; 34 years ago</td></tr><tr><th>Headquarters</th><td>Eastview/Tarrytown, New York, US (global headquarters)</td></tr><tr><th>Area served</th><td>Global</td></tr><tr><th>Key people</th><td>Leonard Schleifer | (CEO) | George Yancopoulos | (CSO)</td></tr><tr><th>Revenue</th><td> US$8.497 billion (2020)</td></tr><tr><th>Net income</th><td> US$3.513 billion (2020)</td></tr><tr><th>Total assets</th><td> US$17.163 billion (2020)</td></tr><tr><th>Number of employees</th><td>9,123 (2020)</td></tr><tr><th>Website</th><td>www | .regeneron | .com</td></tr></table>